rs143439055
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 4P and 9B. PVS1_StrongBP6BA1
The NM_003465.3(CHIT1):c.1155_1156+2del variant causes a splice donor, coding sequence change. The variant allele was found at a frequency of 0.0045 in 1,613,672 control chromosomes in the GnomAD database, including 264 homozygotes. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.024 ( 129 hom., cov: 33)
Exomes 𝑓: 0.0025 ( 135 hom. )
Consequence
CHIT1
NM_003465.3 splice_donor, coding_sequence
NM_003465.3 splice_donor, coding_sequence
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.60
Genes affected
CHIT1 (HGNC:1936): (chitinase 1) Chitotriosidase is secreted by activated human macrophages and is markedly elevated in plasma of Gaucher disease patients. The expression of chitotriosidase occurs only at a late stage of differentiation of monocytes to activated macrophages in culture. Human macrophages can synthesize a functional chitotriosidase, a highly conserved enzyme with a strongly regulated expression. This enzyme may play a role in the degradation of chitin-containing pathogens. Several alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Jan 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates 0.17558886509635974 fraction of the gene. Cryptic splice site detected, with MaxEntScore 5.1, offset of 4, new splice context is: taaGTaagg. Cryptic site results in frameshift change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
BP6
Variant 1-203217736-TACTC-T is Benign according to our data. Variant chr1-203217736-TACTC-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 294917.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Uncertain_significance=1}.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0796 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHIT1 | NM_003465.3 | c.1155_1156+2del | splice_donor_variant, coding_sequence_variant | 10/11 | ENST00000367229.6 | NP_003456.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHIT1 | ENST00000367229.6 | c.1155_1156+2del | splice_donor_variant, coding_sequence_variant | 10/11 | 1 | NM_003465.3 | ENSP00000356198 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0236 AC: 3586AN: 151944Hom.: 128 Cov.: 33
GnomAD3 genomes
AF:
AC:
3586
AN:
151944
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00615 AC: 1545AN: 251072Hom.: 57 AF XY: 0.00436 AC XY: 591AN XY: 135694
GnomAD3 exomes
AF:
AC:
1545
AN:
251072
Hom.:
AF XY:
AC XY:
591
AN XY:
135694
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00250 AC: 3648AN: 1461610Hom.: 135 AF XY: 0.00222 AC XY: 1616AN XY: 727122
GnomAD4 exome
AF:
AC:
3648
AN:
1461610
Hom.:
AF XY:
AC XY:
1616
AN XY:
727122
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0237 AC: 3606AN: 152062Hom.: 129 Cov.: 33 AF XY: 0.0222 AC XY: 1652AN XY: 74320
GnomAD4 genome
AF:
AC:
3606
AN:
152062
Hom.:
Cov.:
33
AF XY:
AC XY:
1652
AN XY:
74320
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
20
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Chitotriosidase deficiency Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | The CHIT1 c.1155_1156+2delGAGT variant occurs in a canonical splice site (donor) and is therefore predicted to disrupt or distort the normal gene product. The variant has been reported in one study where CHIT1 genotyping of patients with Gaucher disease was performed to assess possible issues with therapeutic monitoring (Adelino et al. 2012). In this study, the c.1155_1156+2delGAGT variant was found in a one patient with Gaucher disease along with a second missense variant that is known to reduce chitotriosidase enzyme activity. It was noted that this patient also carried a common allele in this gene (duplication of 24 bp in exon 11 of the CHIT1 gene): an allele which is known to lead to an absence of chitotriosidase enzyme activity. The phase of these variants in this individual is unknown. Control data are unavailable for this variant, which is reported at a frequency of 0.12963 in the Yoruba Nigerian population of the 1000 Genomes Project. Based on the potential impact of splice variants and the limited evidence, the c.1155_1156+2delGAGT variant is classified as a variant of unknown significance but suspicious for pathogenicity for chitotriosidase deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
not provided Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Dec 16, 2015 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: -1
DS_DL_spliceai
Position offset: 3
Find out detailed SpliceAI scores and Pangolin per-transcript scores at